Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 28:19:589-597.
doi: 10.2147/CIA.S438541. eCollection 2024.

Characteristics and Prognosis of Type 2 Myocardial Infarction Through Worsening Renal Function and NT-proBNP in Older Adults with Pneumonia

Affiliations

Characteristics and Prognosis of Type 2 Myocardial Infarction Through Worsening Renal Function and NT-proBNP in Older Adults with Pneumonia

Jinling Ma et al. Clin Interv Aging. .

Abstract

Background: Type 2 myocardial infarction (MI) is becoming more recognized. This study aimed to assess the factors linked to type 2 MI in older adults with pneumonia and further determine the predictive factors of 90-day adverse events (refractory heart failure, cardiogenic shock, and all-cause mortality).

Methods: A single-center retrospective analysis was conducted among older adults with pneumonia. The primary outcome was the prevalence of type 2 MI. The secondary objective was to assess the adverse events in these patients with type 2 MI within 90 days.

Results: A total of 2618 patients were included. Of these, 361 patients (13.8%) suffered from type 2 MI. Multivariable predictors of type 2 MI were chronic kidney disease (CKD), age-adjusted Charlson comorbidity index (ACCI) score, and NT-proBNP > 4165pg/mL. Moreover, the independent predictive factors of 90-day adverse events included NT-proBNP > 4165pg/mL, age, ACCI score, and CKD. The Kaplan-Meier adverse events curves revealed that the type 2 MI patients with CKD and NT-proBNP > 4165pg/mL had a higher risk than CKD or NT-proBNP > 4165pg/mL alone.

Conclusion: Type 2 MI in older pneumonia hospitalization represents a heterogeneous population. Elevated NT-proBNP level and prevalence of CKD are important predictors of type 2 MI and 90-day adverse events in type 2 MI patients.

Keywords: mortality; older; pneumonia; type 2 myocardial infarction.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Associations of risk factors with type 2 MI in older adults with pneumonia.
Figure 2
Figure 2
Associations of risk factors with 90-day adverse events in older pneumonia patients of type 2 MI.
Figure 3
Figure 3
Kaplan–Meier 90-day adverse events (refractory heart failure, cardiogenic shock, and all-cause death) curves according to NT-proBNP level and CKD.
Figure 4
Figure 4
Kaplan–Meier 90-day adverse events (refractory heart failure, cardiogenic shock, and all-cause death) curves according to NT-proBNP level and CKD.

References

    1. Smer A, Squires RW, Aboeata A, et al. Type 2 myocardial infarction: current concepts and our experience with cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2021;41(3):147–152. doi:10.1097/HCR.0000000000000550 - DOI - PubMed
    1. Nestelberger T, Boeddinghaus J, Badertscher P, et al. Effect of definition on incidence and prognosis of type 2 myocardial infarction. J Am Coll Cardiol. 2017;70(13):1558–1568. doi:10.1016/j.jacc.2017.07.774 - DOI - PubMed
    1. Sandoval Y, Jaffe AS. Type 2 myocardial infarction: JACC review topic of the week. J Am Coll Cardiol. 2019;73(14):1846–1860. doi:10.1016/j.jacc.2019.02.018 - DOI - PubMed
    1. Singh A, Gupta A, DeFilippis EM, et al. Cardiovascular mortality after type 1 and type 2 myocardial infarction in young adults. J Am Coll Cardiol. 2020;75(9):1003–1013. doi:10.1016/j.jacc.2019.12.052 - DOI - PMC - PubMed
    1. Chapman AR, Shah ASV, Lee KK, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137(12):1236–1245. doi:10.1161/CIRCULATIONAHA.117.031806 - DOI - PMC - PubMed